The future of a potential new blockbuster pain killer under development by AstraZeneca is in doubt after it failed safety …
Eli Lilly and Sankyo Pharma UK are to share sales representatives in an innovative new arrangement co-ordinated by contract sales …
A campaign to raise PCT awareness of the new Primary Care Drug Dictionary (PCCD) has been launched to promote its …
AstraZeneca's Crestor is to receive an immediate launch in its first market after Canada's regulator's approved the new cholesterol lowering …
GlaxoSmithKline has received mixed news in the on-going patent battle with Canadian generics company Apotex over its biggest selling drug, …
Pfizer's blockbuster hypertension and angina treatment Norvasc could face competition from a related drug following a US court ruling.A ruling …
The poorest performing NHS hospitals could now be run by private companies under new plans unveiled by the Government.Eight private …
The safety and efficacy of new surgical and non-surgical interventions are to be assessed as part of a new NICE …
Galen has bolstered its product range by buying the rights to pre-menstrual syndrome treatment Sarafem from Lilly for $295 million.Shares …
A new UK High Court ruling has given pharma companies the right to block the sale of re-packaged parallel imports …
Three pharmaceutical companies, GlaxoSmithKline, Pharmacia and Aventis, face legal action for alleged bribery and inflation of prescription drug prices in …
Smaller local hospitals are to become important centres for developing patient-centred care in a reversal of what the Government calls …
Fourteen PCTs have been given the go-ahead to develop new and innovative services and improve patient services through community pharmacists.Local …